The Necessity of Bone Densitometry for Patients Taking Selective Serotonin Reuptake Inhibitors
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: To analyze the necessity of bone densitometry for patients long-term tak-ing selective serotonin reuptake inhibitors (SSRI) over a long period of time, which is one of the risk factors of osteoporosis. Methods: We selected patients from 5 veterans hospi-tals who took SSRI for more than 2 months while taking bone densitometry on a regular basis. Results: Of the 85 patients from a total of 5 veterans hospitals taking SSRI for more than two months, only 34 patients were under diagnosis and treatment measures of os-teoporosis through checking each person’s bone mineral density. Conclusions: It is nec -essary for patients taking SSRI to check bone density on a regular basis.
Abstract
Background: To analyze the necessity of bone densitometry for patients long-term tak-ing selective serotonin reuptake inhibitors (SSRI) over a long period of time, which is one of the risk factors of osteoporosis. Methods: We selected patients from 5 veterans hospi-tals who took SSRI for more than 2 months while taking bone densitometry on a regular basis. Results: Of the 85 patients from a total of 5 veterans hospitals taking SSRI for more than two months, only 34 patients were under diagnosis and treatment measures of os-teoporosis through checking each person’s bone mineral density. Conclusions: It is nec -essary for patients taking SSRI to check bone density on a regular basis.
참고문헌 (15)
- Physician’s guide for diagnosis & treatment of osteoporosis, "Kang MI", Korean Society for Bone and Mineral Research, ~ (2008)
- Cummings SR, "Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group", JAMA, 263, pp.665~668 (1990)
- Yirmiya R, "Major depression is a risk factor for low bone mineral density: a meta-analysis", Biol Psychiatry, 66, pp.423~432 (2009)
- Richards JB, "Effect of selective serotonin reuptake inhibitors on the risk of fracture", Arch Intern Med, 167, pp.188~194 (2007)
- Pacher P, "Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivity", Br J Pharmacol, 127, pp.740~746 (1999)
- Ungvari Z, "Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca (2+) channel opener", Stroke, 30, pp.1949~1954 (1999)
- Cherin P, "Risk of syncope in the elderly and consumption of drugs: a case-control study", J Clin Epidemiol, 50, pp.313~320 (1997)
- Vaswani M, "Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review", Prog Neuropsychopharmacol Biol Psychiatry, 27, pp.85~102 (2003)
- Korea health statistics 2009: Korea national health and nutrition examination survey, "Ministry of Health & Welfare", Ministry of Health & Welfare, ~, pp.KNHANESIV- 3 (2010)
- Haney EM, "Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men", Arch Intern Med, 167, pp.1246~1251 (2007)
- Yadav VK, "Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum", Cell, 135, pp.825~837 (2008)
- Ohayon MM, "Prevalence of major depressive disorder in the general population of South Korea", J Psychiatr Res, 40, pp.30~36 (2006)
- MacGillivray S, "Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis", BMJ, 326, pp.1014~ (2003)
- Anderson IM, "Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis", BMJ, 310, pp.1433~1438 (1995)
- Barbui C, "Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence", Cochrane Database Syst Rev, 4, pp.CD002791~ (2000)